...Show More Authors
Background: The iron deficiency anemia along with hyperphosphatemia are the main complications of dialysis patients. Traditional iron
supplement has been failed to correct iron deficiency anemia, therefore, the current study aimed to investigate the efficacy and tolerability of
new phosphate binder, ferric citrate, in a sample of Iraqi patients with end stage renal disease on maintenance hemodialysis.
Method: Prospective, randomized, open label, active controlled trial was conducted in one center for dialysis in Babylon governance.
Patients were randomized to receive ferric citrate with dose of 6 g/d and calcium carbonate with dose of 3 g/d for eight weeks. Hemoglobin
concentration, mean corpuscular hemoglobin concentration and count o
...
Show More